application) Transplantation of islets of Langerhans into the diabetic patient possesses the potential to reverse long-term hyperglycemia through tightly regulated physiological changes of serum insulin levels. To date long-term success of islet transplants has been limited. The reasons for this are not completely understood but it has been hypothesized that long-term failure of the transplanted graft to maintain normoglycemia results from a loss in B-cell mass and/or function over time. The overall goal of the proposed research is to develop capabilities for in vivo evaluation of pancreatic islet mass and function at various temporal stages following transplantation. The research strategy will include development of transgenic mice, producing pancreatic islets with """"""""imagable"""""""" insulin-secreting B-cells, characterization of these islets with regards to B-cell mass, function and apoptosis and subsequent transplantation of transgenic islets into nude mice, allowing posttransplantation studies of graft mass and function with time. Since the grafts are vascularized and the experiments will be performed with the kidney connected to the circulatory system of the mouse, this will also provide the first steps towards evaluation of B-cell signal-transduction under in vivo conditions. More specifically we will: 1. Develop methodologies for in vivo imaging of B-cell mass in transplanted islets of Langerhans; 2. Develop and apply novel methodologies for in vivo monitoring of B-cell function within the islet graft; 3. Develop and apply methods to allow in vivo detection of B-cell apoptosis within the islet graft. At the end of this grant period we should be in the position to address the molecular mechanisms resulting in B-cell incapacitation following transplantation of functional islets into diabetic recipients and to possess the necessary methodologies to investigate signal-transduction in pancreatic B-cells under in vivo conditions and in situ.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK058508-05
Application #
6795399
Study Section
Special Emphasis Panel (ZDK1-GRB-3 (O1))
Program Officer
Laughlin, Maren R
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
5
Fiscal Year
2004
Total Cost
$250,000
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 7-7
Leibiger, I B; Caicedo, A; Berggren, P-O (2012) Non-invasive in vivo imaging of pancreatic *-cell function and survival - a perspective. Acta Physiol (Oxf) 204:178-85
Speier, Stephan; Nyqvist, Daniel; Kohler, Martin et al. (2008) Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 3:1278-86
Speier, Stephan; Nyqvist, Daniel; Cabrera, Over et al. (2008) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574-8
von Seth, Erik; Nyqvist, Daniel; Andersson, Arne et al. (2007) Distribution of intraportally implanted microspheres and fluorescent islets in mice. Cell Transplant 16:621-7
Richard, Ann-Marie T; Webb, Dominic-Luc; Goodman, Jessie M et al. (2007) Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion. Am J Physiol Endocrinol Metab 293:E794-801
Berggren, Per-Olof; Leibiger, Ingo B (2006) Novel aspects on signal-transduction in the pancreatic beta-cell. Nutr Metab Cardiovasc Dis 16 Suppl 1:S7-10
Cabrera, Over; Berman, Dora M; Kenyon, Norma S et al. (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334-9
Yang, Shao-Nian; Berggren, Per-Olof (2006) The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology. Endocr Rev 27:621-76
Nyqvist, Daniel; Kohler, Martin; Wahlstedt, Helene et al. (2005) Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 54:2287-93
Lilja, Lena; Meister, Bjorn; Berggren, Per-Olof et al. (2005) DARPP-32 and inhibitor-1 are expressed in pancreatic beta-cells. Biochem Biophys Res Commun 329:673-7

Showing the most recent 10 out of 28 publications